Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Nov 27, 2026; 18(11): 124439
Published online Nov 27, 2026. doi: 10.4254/wjh.124439
Published online Nov 27, 2026. doi: 10.4254/wjh.124439
Association between fibrosis-4 index and all-cause mortality by hepatic steatosis category in United States adults: A retrospective cohort study
Jing Lu, Chao Guo, Qing-Quan Gong, Department of Gastroenterology, Mindong Hospital Affiliated to Fujian Medical University, Ningde 355000, Fujian Province, China
Zhao-Yun Liu, Department of Gastroenterology, Ningde Municipal Hospital, Ningde 352100, Fujian Province, China
Co-first authors: Jing Lu and Zhao-Yun Liu.
Author contributions: Lu J and Liu ZY designed the study, curated the data, performed the statistical analyses, interpreted the findings, and drafted the manuscript, both authors have made crucial and indispensable contributions towards the completion of the project and thus qualified as the co-first authors of the paper; Guo C contributed to the methodological design, clinical interpretation, study supervision, and critical revision of the manuscript; Gong QQ conceived and supervised the study, interpreted the findings, critically revised the manuscript, and coordinated submission.
AI contribution statement: During manuscript revision, ChatGPT (OpenAI, GPT-6) was used to assist with editorial wording, verification of publicly available source links, and table formatting. All AI-assisted revisions were reviewed and verified by the authors, who take full responsibility for the accuracy, integrity, and scientific content of the manuscript.
Supported by Fujian University of Traditional Chinese Medicine, No. XB2024208.
Institutional review board statement: The National Health and Nutrition Examination Survey protocols were approved by the National Center for Health Statistics Research Ethics Review Board. The present study used only publicly available, deidentified secondary data and did not involve renewed contact with participants.
Informed consent statement: All participants provided written informed consent in the original National Health and Nutrition Examination Survey cycles.
Conflict-of-interest statement: The authors declare no conflicts of interest related to this study.
STROBE statement: The authors have read the STROBE Statement, and the manuscript was prepared and revised in accordance with the STROBE reporting recommendations for observational studies.
Data sharing statement: The National Health and Nutrition Examination Survey data and the 2019 public-use linked mortality files used in this study are publicly available from the National Center for Health Statistics. The 2019 Continuous NHANES Public-use Linked Mortality Files and supporting documentation are accessible through the NCHS data linkage portal (https://www.cdc.gov/nchs/linked-data/mortality-files/index.html). No new restricted dataset was generated. The analytic R scripts and a reproducibility README are provided in the Supplementary Code package.
Corresponding author: Qing-Quan Gong, MD, Adjunct Associate Professor, Department of Gastroenterology, Mindong Hospital Affiliated to Fujian Medical University, No. 89 Heshan Road, Ningde 355000, Fujian Province, China. gqq96398@sina.com
Received: June 15, 2026
Revised: August 25, 2026
Accepted: November 5, 2026
Published online: November 27, 2026
Processing time: 158 Days and 0.5 Hours
Revised: August 25, 2026
Accepted: November 5, 2026
Published online: November 27, 2026
Processing time: 158 Days and 0.5 Hours
Core Tip
Core Tip: Elevated fibrosis-4 index (FIB-4) was associated with higher all-cause mortality within the hepatic steatosis index (HSI) 30-36 and > 36 categories, but the overall interaction was not statistically significant. The observed gains in predictive performance were statistically detectable but small and do not establish clinical utility. Because HSI and FIB-4 share aminotransferase components and FIB-4 is influenced by age and platelet count, elevated FIB-4 should be interpreted as a composite risk marker rather than direct evidence of advanced liver fibrosis.